Financial Statements · Financial Reporting
Bioforce Group OÜ
Official identifier 16260737Record date 31 Dec 2023
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2023
- Period start
- 1 Jan 2023
- Submitted date
- 17 Dec 2024
Report
- Consolidated
- Yes
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Profit distribution proposal | Retained earnings (loss) from previous periods | 1,039,522 |
| Unconsolidated bilanss | Assets | 21,120,186 |
| Unconsolidated bilanss | Cash and cash equivalents | 4,617 |
| Unconsolidated bilanss | Current assets | 992,915 |
| Unconsolidated bilanss | Current liabilities | 1,179,935 |
| Unconsolidated bilanss | Equity | 18,786,077 |
| Unconsolidated bilanss | Share capital at nominal value | 8,140 |
| Unconsolidated bilanss | Non-current assets | 20,127,271 |
| Unconsolidated bilanss | Non-current liabilities | 1,154,174 |
| Unconsolidated bilanss | Retained earnings (loss) from previous periods | -556,608 |
| Unconsolidated income statement (scheme 1) | Depreciation and impairment of non-current assets | -2,592 |
| Unconsolidated income statement (scheme 1) | Labour costs | -59,458 |
| Unconsolidated income statement (scheme 1) | Revenue | 3,550,178 |
| Unconsolidated income statement (scheme 1) | Annual period profit / loss | 3,091,992 |
| Unconsolidated income statement (scheme 1) | Operating profit (loss) | 2,621,206 |
| Unconsolidated income statement (scheme 1) | Profit (loss) before income tax | 3,091,992 |
| Unconsolidated rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 2,591 |
| Unconsolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 2,621,206 |
| Consolidated bilanss | Assets | 28,927,304 |
| Consolidated bilanss | Cash and cash equivalents | 803,395 |
| Consolidated bilanss | Current assets | 4,136,178 |
| Consolidated bilanss | Current liabilities | 5,784,670 |
| Consolidated bilanss | Equity | 5,114,138 |
| Consolidated bilanss | Share capital at nominal value | 8,140 |
| Consolidated bilanss | Non-current assets | 24,791,126 |
| Consolidated bilanss | Non-current liabilities | 18,028,496 |
| Consolidated bilanss | Retained earnings (loss) from previous periods | 1,039,522 |
| Consolidated income statement scheme 1 | Depreciation and impairment of non-current assets | -1,465,012 |
| Consolidated income statement scheme 1 | Labour costs | -1,180,724 |
| Consolidated income statement scheme 1 | Revenue | 20,782,909 |
| Consolidated income statement scheme 1 | Annual period profit / loss | 3,422,058 |
| Consolidated income statement scheme 1 | Profit (loss) before income tax | 3,547,108 |
| Consolidated income statement scheme 1 | Operating profit (loss) | 4,263,359 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 1,465,012 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 4,263,359 |
| Note: Labour costs | Employees | 24 |
| Note: Labour costs | Labour costs | 1,180,724 |
| Employees | 24 |
Linked company
Company: Bioforce Group OÜ